Key facts
- This page summarizes Alexandre Weinstein Manieu's Form 3 filing for Sofgen Pharma S.A..
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Mar 2026, 07:39.
Alexandre Weinstein Manieu - 18 Mar 2026 Form 3 Insider Report for Sofgen Pharma S.A.
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- PROCF, PRCWF on OTC
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 19 Mar 2026, 07:39:37 UTC
- Prior SEC filing
- 05 Jan 2026
- Next SEC filing
- 04 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alexandre Weinstein Manieu
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alexandre Weinstein Manieu filed Form 3 for Sofgen Pharma S.A. on 19 Mar 2026.
Change
- Previous filing in this sequence was filed on 05 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001833124
Primary reporting owner
Manieu Alexandre Weinstein
- Relationship
- Director, 10%+ Owner
- Address
- APT 8002, BURGENSTOCK HOTELS & RESORT, BURGENSTOCK 3, OBBURGEN, SWITZERLAND
- Signature
- /s/ Alexandre Weinstein Manieu
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
No ticker
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 626,495,816
- Date
- 18 Mar 2026
- Ownership
- By Hoche Partners Pharma Holdings LLC
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No ticker
holding
Derivative
Warrant to Purchase Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- By Hoche Partners Pharma Holdings LLC
- Underlying class
- Ordinary Shares
- Underlying amount
- 79,201,647
- Exercise price
- $0.0631
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents Ordinary Shares beneficially owned by Hoche Partners Pharma Holdings LLC ("Hoche"), an entity controlled by Mr. Weinstein.
Footnote F2
Represents a warrant to purchase Ordinary Shares beneficially owned by Hoche, an entity controlled by Mr. Weinstein.